Adicet Bio (ACET)
3.99
-0.29 (6.78%)
Upcoming Events
Latest Headlines
Form SCHEDULE 13G Adicet Bio, Inc. Filed by: Zedek Daniel Clayton
October 23, 2026 5:49 PM - SEC Filing
Adicet Bio to Participate in Upcoming Investor Conferences
October 22, 2026 4:00 PM - BizWire
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
September 30, 2026 7:12 PM - BizWire
Adicet Bio Inc. (ACET) PT Raised to $34 at H.C. Wainwright
September 29, 2026 6:47 AM - StreetInsider
Adicet Bio Inc. (ACET) PT Raised to $28 at Wedbush
September 28, 2026 9:57 AM - StreetInsider
Form 8-K Adicet Bio, Inc. For: Sep 28
September 28, 2026 8:16 AM - SEC Filing
Adicet Bio reports Phase 1 lupus trial data for prula-cel
September 28, 2026 6:46 AM - StreetInsider
Adicet Bio Announces Positive Safety and Efficacy Data from Prula-cel (formerly ADI-001) Study in Patients with Systemic Lupus Erythematosus with or without Lupus Nephritis
September 28, 2026 6:45 AM - BizWire
Adicet Bio to Host Webcast to Present Prula-cel (formerly ADI-001) Clinical Data in Patients with Systemic Lupus Erythematosus with or without Lupus Nephritis
September 25, 2026 4:00 PM - BizWire
H.C. Wainwright Reiterates Buy Rating on Adicet Bio Inc. (ACET)
September 21, 2026 7:33 AM - StreetInsider
FDA clears Adicet Bio IND application for prostate cancer therapy
August 27, 2026 4:00 PM - StreetInsider
Adicet Bio Announces FDA Clearance of IND Application for ADI-212
August 27, 2026 4:00 PM - BizWire
Form SCHEDULE 13G/A Adicet Bio, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
August 14, 2026 4:45 PM - SEC Filing
Form 4 Adicet Bio, Inc. For: Aug 05 Filed by: Klickstein Lloyd
August 7, 2026 4:02 PM - SEC Filing
Adicet Bio Inc. (ACET) PT Lowered to $90 at Guggenheim
August 6, 2026 6:44 AM - StreetInsider
Form 10-Q Adicet Bio, Inc. For: Jun 30
August 5, 2026 4:26 PM - SEC Filing
Form 8-K Adicet Bio, Inc. For: Aug 05
August 5, 2026 4:23 PM - SEC Filing
Adicet Bio Reports Second Quarter 2026 Financial Results and Provides Business Updates
August 5, 2026 4:15 PM - BizWire
Lipocine names former Johnson & Johnson executive to its board
August 3, 2026 8:00 AM - StreetInsider
Lipocine Appoints Michael J. Grissinger to Board of Directors
August 3, 2026 8:00 AM - PR NewsWire
Full Article List
